Research Solutions

The BostonGene Tumor Portrait™ Test depicts tumor activity, tumor cellular composition, immune microenvironment activity, and other tumor-associated processes to identify active or suppressed processes in patient tumors to ultimately guide therapeutic decision-making.

BostonGene analyzes surface receptor expression based on transcriptomic data and deconvolution algorithms to simplify cell-cell interactions.

BostonGene’s proprietary validated algorithms predict tumor antigenicity and calculate expressed neoantigenic peptides derived from mutated and fusion proteins.

BostonGene analyzes the functional and transcriptomic effects of genomic alterations by utilizing the complete spectrum of protein-protein interactions in a comprehensive map of signaling pathways.

BostonGene cancer reactive profiling of T and B cells immune cell repertoire in the tumor microenvironment in solid cancer as well as the identification of major malignant clones of T and B cells in hematological malignancies leads to a better understanding of tumor progression and evolution.

BostonGene analyzes the expression of all transcripts, single genes, and functional gene signatures to understand multiple aspects of the biology of the tumor and microenvironment.

BostonGene identifies genomic alteration across the entire exome including point mutations, indels, tumor mutational burden (TMB), copy number alteration and HRR gene mutations.

BostonGene assesses the subclonal heterogeneity and evolution of malignant cells within the tissue to understand tumor progression.

BostonGene decodes the tumor microenvironment via deconvolution of cellular components by proprietary machine learning algorithms analyzing bulk RNA-seq, enabling the accurate reconstruction of the microenvironment.

BostonGene detects cancer-associated viral or bacterial infections relevant for diagnostics and therapy selection.